XML 107 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Stockholders' Equity | 12 Months Ended
--- | ---
Jul. 31, 2013
Equity [Abstract] |
Shareholders' Equity |
(11) |  | Stockholders’ Equity
General The Company has authorized the issuance of 180 million shares of common stock, with a par value of $0.0001, of which 125,494,995 shares were issued and outstanding at July 31, 2013. As of July 31, 2013 and 2012, the Company has reserved 16,606,389 and 18,170,575 shares of common stock, respectively, for the issuance of options granted under the Company’s stock option plans and 1,240,888 and 1,325,651 shares of common stock, respectively, for the issuance of shares under the Copart, Inc. Employee Stock Purchase Plan (ESPP). The Company has authorized the issuance of 5 million shares of preferred stock, with a par value of $0.0001, none of which were issued or outstanding at July 31, 2013 or 2012, which have the rights and preferences as the Company’s Board of Directors shall determine, from time to time. Stock Repurchase On September 22, 2011, the Company’s board of directors approved a 40 million share increase in the Company’s stock repurchase program that was originally implemented in 2003, bringing the total current authorization to 98 million shares. The repurchases may be effected through solicited or unsolicited transactions in the open market or in privately negotiated transactions. No time limit has been placed on the duration of the stock repurchase program. Subject to applicable securities laws, such repurchases will be made at such times and in such amounts as the Company deems appropriate and may be discontinued at any time. For the year ended July 31, 2013, the Company repurchased 500,000 shares of our common stock at a weighted average price of $27.77. For the year ended July 31, 2012, the Company repurchased 8,880,708 shares of our common stock at a weighted average price of $22.51. For the year ended July 31, 2011, the Company repurchased 13,364,634 shares of our common stock at a weighted average price of $20.42. As of July 31, 2013, the total number of shares repurchased under the program was 50,286,782 and 47,713,218 shares were available for repurchase under the program. See Note 17. Related Party Transactions, for discussion of related party stock repurchases. Additionally, on January 14, 2011, the Company completed a tender offer to purchase up to 21,052,630 shares of its common stock at a price of $19.00 per share. Directors and executive officers of Copart were expressly prohibited from participating in the tender offer by our board of directors under the Company’s Insider Trading Policy. In connection with the tender offer, the Company accepted for purchase 24,344,176 shares of its common stock. The shares accepted for purchase are comprised of the 21,052,630 shares the Company offered to purchase and an additional 3,291,546 shares purchased pursuant to the Company’s right to purchase additional shares up to 2% of its outstanding shares. The shares purchased as a result of the tender offer are not part of the Company’s repurchase program. The purchase of the shares of common stock was funded by the proceeds relating to the issuance of long term debt. The impact dilutive earnings per share of all repurchased shares on the weighted average number of common shares outstanding for the year ended July 31, 2013 is less than $0.01. In the second, third and fourth quarters of fiscal year 2011, certain executive officers exercised stock options through cashless exercises. In the first, second and third quarters of fiscal year 2012 and the second quarter of fiscal year 2013, certain executive officers exercised stock options through cashless exercises. A portion of the options exercised were net settled in satisfaction of the exercise price and federal and state minimum statutory tax withholding requirements. The Company remitted $0.6 million, $2.6 million and $4.2 million, in fiscal 2013, 2012 and 2011, respectively, to the proper taxing authorities in satisfaction of the employees’ minimum statutory withholding requirements. The exercises are summarized in the following table:
Period |  |  |  | Options Exercised |  | Exercise Price |  | Shares Net Settled for Exercise |  | Shares Withheld for Taxes(1) |  | Net Shares to Employee |  | Share Price for Withholding |  | Tax Withholding (in 000’s)
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
FY 2011—Q2 |  |  |  |  | 177,500 |  |  | $ | 8.47 |  |  |  | 76,050 |  |  |  | 37,834 |  |  |  | 63,616 |  |  | $ | 19.76 |  |  | $ | 748 |
FY 2011—Q3 |  |  |  |  | 548,334 |  |  | $ | 11.02 |  |  |  | 295,496 |  |  |  | 118,032 |  |  |  | 134,806 |  |  | $ | 20.40 |  |  | $ | 2,408 |
FY 2011—Q4 |  |  |  |  | 180,000 |  |  | $ | 9.48 |  |  |  | 76,396 |  |  |  | 48,366 |  |  |  | 55,238 |  |  | $ | 22.33 |  |  | $ | 1,080 |
FY 2012—Q1 |  |  |  |  | 40,000 |  |  | $ | 9.00 |  |  |  | 16,082 |  |  |  | 8,974 |  |  |  | 14,944 |  |  | $ | 22.39 |  |  | $ | 201 |
FY 2012—Q2 |  |  |  |  | 20,000 |  |  | $ | 9.00 |  |  |  | 7,506 |  |  |  | 4,584 |  |  |  | 7,910 |  |  | $ | 23.98 |  |  | $ | 110 |
FY 2012—Q3 |  |  |  |  | 322,520 |  |  | $ | 10.74 |  |  |  | 131,299 |  |  |  | 85,683 |  |  |  | 105,538 |  |  | $ | 26.38 |  |  | $ | 2,260 |
FY 2013—Q2 |  |  |  |  | 73,228 |  |  | $ | 8.89 |  |  |  | 18,127 |  |  |  | 17,461 |  |  |  | 37,640 |  |  | $ | 35.91 |  |  | $ | 627 |
(1) |  | Shares withheld for taxes are treated as a repurchase of shares for accounting purposes but do not count against the Company’s stock repurchase program.
Employee Stock Purchase Plan The ESPP provides for the purchase of up to an aggregate of 5 million shares of common stock of the Company by employees pursuant to the terms of the ESPP. The Company’s ESPP was adopted by the Board of Directors and approved by the stockholders in 1994. The ESPP was amended and restated in 2003 and again approved by the stockholders. Under the ESPP, employees of the Company who elect to participate have the right to purchase common stock at a 15 percent discount from the lower of the market value of the common stock at the beginning or the end of each six month offering period. The ESPP permits an enrolled employee to make contributions to purchase shares of common stock by having withheld from their salary an amount up to 10 percent of their compensation (which amount may be increased from time to time by the Company but may not exceed 15% of compensation). No employee may purchase more than $25,000 worth of common stock (calculated at the time the purchase right is granted) in any calendar year. The Compensation Committee of the Board of Directors administers the ESPP. The number of shares of common stock issued pursuant to the ESPP during each of fiscal 2013, 2012 and 2011 was 84,761, 97,769 and 127,192, respectively. As of July 31, 2013, there have been 3,759,112 shares of common stock issued pursuant to the ESPP and 1,240,888 shares remain available for purchase under the ESPP. Stock Options In December 2007, the Company adopted the Copart, Inc. 2007 Equity Incentive Plan (the Plan), presently covering an aggregate of 8.0 million shares of the Company’s common stock. The Plan provides for the grant of incentive stock options, restricted stock, restricted stock units and other equity-based awards to employees and non-qualified stock options, restricted stock, restricted stock units and other equity-based awards to employees, officers, directors and consultants at prices not less than 100% of the fair market value for incentive and non-qualified stock options, as determined by the Board of Directors at the grant date. Incentive and non-qualified stock options may have terms of up to ten years and vest over periods determined by the Board of Directors. Options generally vest ratably over a five-year period. The Plan replaced the Company’s 2001 Stock Option Plan. At July 31, 2013, 1,684,091 shares were available for future grant under the Plan. In April 2009, the Compensation Committee of the Company’s Board of Directors, following stockholder approval of proposed grants at a special meeting of stockholders, approved the grant to each Willis J. Johnson, the Company’s Chairman (and then Chief Executive Officer), and A. Jayson Adair, the Company’s Chief Executive Office (and then President), of nonqualified stock options to purchase 4,000,000 shares of the Company’s common stock at an exercise price of $15.11 per share, which equaled the closing price of the Company’s common stock on April 14, 2009, the effective date of grant. Such grants were made in lieu of any cash salary or bonus compensation in excess of $1.00 per year or the grant of any additional equity incentives for a five-year period. Each option will become exercisable over five years, subject to continued service by the executive, with twenty percent (20%) vesting on April 14, 2010, and the balance vesting ratably over the subsequent four years. Each option will become fully vested, assuming continued service, on April 14, 2014, the fifth anniversary of the date of grant. If, prior to a change in control, either executive’s employment is terminated without cause, then one hundred percent (100%) of the shares subject to that executive’s stock option will immediately vest. If, upon or following a change in control, either the Company or a successor entity terminates the executive’s service without cause, or the executive resigns for good reason, then one hundred percent (100%) of the shares subject to his stock option will immediately vest. The total compensation expense to be recognized by the Company over the five year service period is $26.1 million dollars per grant. The Company recognized $10.2 million in compensation expense in fiscal 2013, 2012 and 2011, relating to these grants. The following table sets forth stock-based compensation expense included in the company’s consolidated statements of income (in thousands):
|  |  |  | Years Ended July 31, |
--- | --- | --- | --- | --- | ---
|  |  |  | 2013 |  | 2012 |  | 2011
General and administrative |  |  |  | $ | 17,135 |  |  | $ | 18,802 |  |  | $ | 17,976 |
Yard operations |  |  |  |  | 2,289 |  |  |  | 2,989 |  |  |  | 1,031 |
Total |  |  |  | $ | 19,424 |  |  | $ | 21,791 |  |  | $ | 19,007 |
There were no material compensation costs capitalized as part of the cost of an asset as of July 31, 2013 and 2012. A summary of the status of the Company’s non-vested shares as of July 31, 2013 and changes during fiscal 2013 is as follows:
|  |  |  | Number of Shares (in 000’s) |  | Weighted Average Grant- date Fair Value
--- | --- | --- | --- | --- | --- | ---
Non-vested shares at July 31, 2012 |  |  |  |  | 6,013 |  |  | $ | 6.59 |
Grants of non-vested shares |  |  |  |  | 335 |  |  |  | 7.87 |
|  |  |  | Number of Shares (in 000’s) |  | Weighted Average Grant- date Fair Value
--- | --- | --- | --- | --- | --- | ---
Vested |  |  |  |  | (2,889 | ) |  |  | 6.57 |
Forfeitures or expirations |  |  |  |  | (63 | ) |  |  | 6.06 |
Non-vested shares at July 31, 2013 |  |  |  |  | 3,396 |  |  | $ | 6.55 |
Option activity for the year ended July 31, 2013 is summarized as follows:
|  |  |  | Shares (in 000’s) |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term |  | Aggregate Intrinsic Value (in 000’s)
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Outstanding at July 31, 2012 |  |  |  |  | 16,179 |  |  | $ | 16.24 |  |  |  | 6.60 |  |  | $ | 121,977 |
Grants of options |  |  |  |  | 335 |  |  |  | 29.76 |  |  |  | — |  |  |  | — |
Exercises |  |  |  |  | (1,529 | ) |  |  | 13.78 |  |  |  | — |  |  |  | — |
Forfeitures or expirations |  |  |  |  | (63 | ) |  |  | 24.50 |  |  |  | — |  |  |  | — |
Outstanding at July 31, 2013 |  |  |  |  | 14,922 |  |  | $ | 16.75 |  |  |  | 5.91 |  |  | $ | 235,086 |
Exercisable at July 31, 2013 |  |  |  |  | 11,526 |  |  | $ | 16.03 |  |  |  | 5.58 |  |  | $ | 190,003 |
Vested and expected to vest at July 31, 2013 |  |  |  |  | 14,438 |  |  | $ | 16.73 |  |  |  | 5.91 |  |  | $ | 227,892 |
As required by ASC 718, the Company made an estimate of expected forfeitures and is recognizing compensation cost only for those equity awards expected to vest. The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e., the difference between the Company’s closing stock price on the last trading day of the year ended July 31, 2013 and the exercise price, times the number of shares) that would have been received by the option holders had all option holders exercised their options on July 31, 2013. The aggregate intrinsic value of options exercised was $25.4 million, $16.6 million and $16.2 million in the fiscal years ended July 31, 2013, 2012 and 2011, respectively, and represents the difference between the exercise price of the option and the estimated fair value of the Company’s common stock on the dates exercised. As of July 31, 2013, the total compensation cost related to non-vested stock-based payment awards granted to employees under the Company’s stock option plans but not yet recognized was $20.4 million, net of estimated forfeitures. This cost will be amortized on a straight-line basis over a weighted average remaining term of 1.83 years and will be adjusted for subsequent changes in estimated forfeitures. The fair value of options vested in fiscal 2013, 2012 and 2011 is $22.9 million, $20.9 million and $19.6 million, respectively. A summary of stock options outstanding and exercisable at July 31, 2013 follows:
|  |  |  | Options Outstanding |  | Options Exercisable |
--- | --- | --- | --- | --- | --- | --- | ---
Range of Exercise Prices |  |  |  | Number Outstanding at July 31, 2013 (in 000’s) |  | Weighted Average Remaining Contractual Life |  | Weighted Average Exercise Price |  | Number Exercisable at July 31, 2013 (in 000’s) |  | Weighted Average Exercise Price
$9.00–$14.88 |  |  |  |  | 774 |  |  |  | 2.90 |  |  | $ | 12.30 |  |  |  | 774 |  |  | $ | 12.30 |
$15.11–$15.11 |  |  |  |  | 8,000 |  |  |  | 5.70 |  |  | $ | 15.11 |  |  |  | 6,800 |  |  | $ | 15.11 |
$16.38–$20.56 |  |  |  |  | 5,063 |  |  |  | 6.11 |  |  | $ | 18.28 |  |  |  | 3,666 |  |  | $ | 17.99 |
$21.05–$35.72 |  |  |  |  | 1,085 |  |  |  | 8.65 |  |  | $ | 25.03 |  |  |  | 286 |  |  | $ | 22.85 |
|  |  |  |  | 14,922 |  |  |  | 5.91 |  |  | $ | 16.75 |  |  |  | 11,526 |  |  | $ | 16.03

X
- Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration